Reply: A multi-society Delphi consensus statement on new... : Hepatology (original) (raw)

Correspondence

Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Lazarus, Jeffrey V.1,2; Newsome, Philip N.3; Francque, Sven M.4,5; Kanwal, Fasiha6,7; Terrault, Norah A.8; Rinella, Mary E.9

1CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, New York, USA

2Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain

3National Institute for Health Research Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham, Birmingham, UK

4Department of Gastroenterology and Hepatology, Antwerp University Hospital, Edegem, Belgium

5Laboratory for Experimental Medicine and Paediatrics, InflaMed Centre of Excellence, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium

6Sections of Gastroenterology and Hepatology and Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA

7VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA

8Gastrointestinal and Liver Disease Division, University of Southern California, Los Angeles, California, USA

9Department of Medicine, University of Chicago, Chicago, Illinois, USA

Correspondence Mary E. Rinella, 5841 S. Maryland Ave, Chicago, IL 60614, USA. Email: [email protected]

Abbreviations: MASH, metabolic dysfunction-associated steatohepatitis; MASLD, metabolic dysfunction-associated steatotic liver disease.

Buy
Corresponding Article